Sales for this month
July 2026Fiscal year ending March 2027The Group discloses monthly the key figures established as management targets.
Generally scheduled for disclosure from the middle of each month onward. Disclosures for June, September, December and March will be made on the same day as the announcement of the quarterly financial results for each quarter.
April: net premiums written of ¥5,134 million, 1,297,369 policies in force, an average retention rate of 88.5%, 20,749 Animal Kenkatsu applications and 22 patents held. May: ¥5,424 million, 1,308,167 policies, 88.2%, 23,085 applications and 22 patents. June: ¥5,220 million, 1,318,043 policies, 88.2%, 19,134 applications and 23 patents. July: ¥5,175 million, 1,326,765 policies, 88.4%, 20,123 applications and 24 patents.
Scope of aggregation: The Group (pet insurance business and synergy creation business)
| Item | Details |
|---|---|
| Month Covered | July 2026 |
| Fiscal Year Covered | Fiscal year ending March 2027 |
| Scope of aggregation | The Group (pet insurance business and synergy creation business) |
| Net sales for the month | ¥5,508 million (net premiums written) |
| Year-on-year change in monthly net sales | 106.4 |
| Key KPIs | Indicator name Number of in-force policies / Value 1,418,029 Engagements / Year on year 106.9 Engagements, Indicator name Average renewal rate / Value 88.7 % / Year on year Previous year: 88.4%, Indicator name Doubutsu Kenkatsu program (gut flora testing) applications / Value 21,023 Engagements / Year on year 104.5 Engagements, Indicator name Patents held / Value 31 Engagements / Year on year 129.2 Engagements, Indicator name JARVIS Tokyo revenue / Value ¥79,196 thousand / Year on year No prior-year figure |
| Monthly Commentary | The Group discloses monthly the key figures established as management targets. |
| Monthly trend for the same period last year | April: net premiums written of ¥5,134 million, 1,297,369 policies in force, an average retention rate of 88.5%, 20,749 Animal Kenkatsu applications and 22 patents held. May: ¥5,424 million, 1,308,167 policies, 88.2%, 23,085 applications and 22 patents. June: ¥5,220 million, 1,318,043 policies, 88.2%, 19,134 applications and 23 patents. July: ¥5,175 million, 1,326,765 policies, 88.4%, 20,123 applications and 24 patents. |
| Next Scheduled Disclosure | Generally scheduled for disclosure from the middle of each month onward. Disclosures for June, September, December and March will be made on the same day as the announcement of the quarterly financial results for each quarter. |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company discloses key figures for its pet insurance business and its synergy-generating businesses aimed at realizing a “prevention-oriented insurance company” as management targets. No reasons were provided for changes in individual indicators.